Phase 2 Readout
CLLS: Phase 2 Readout: lasme-cel
December 31, 2026 · lasme-cel. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Cellectis S.A. (CLLS)
- Drug
- lasme-cel
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: lasme-cel
- Company
- Cellectis S.A. (CLLS)
- Drug
- lasme-cel
- Indication
- r/r B-ALL